MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/acr2.90061

Медицинская библиотека · ACR open rheumatology · 2026

Elevated Serum Proadrenomedullin Levels in Rheumatoid Arthritis Versus Spondyloarthritis: Insights From a Biobank Cohort.

Papastathopoulou Nefeli Stavroula, Assirelli Elisa, Neri Simona, Naldi Susanna, Ciaffi Jacopo, Mancarella Luana, Brusi Veronica, Lisi Lucia, Pignatti Federica, Ruscitti Piero, Ursini Francesco

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Proadrenomedullin (pro-ADM) is a peptide implicated in immunomodulation, with higher levels observed in inflammatory conditions, cardiovascular impairment, and sepsis. Although extensively studied in acute disorders, its potential as a biomarker in inflammatory arthritis remains underexplored. This study aims to examine serum pro-ADM levels across different types of inflammatory arthritis and to investigate correlations with disease characteristics.

METHODS

We included 163 patients with inflammatory arthritis who were prospectively enrolled in our institutional Biobank. Among them, 99 patients had rheumatoid arthritis (RA), 36 patients had psoriatic arthritis (PsA), 22 patients had axial spondyloarthritis (axSpA), and 6 patients had undifferentiated spondyloarthritis (uSpA). Serum pro-ADM levels were measured using enzyme-linked immunosorbent assay, with cross-sectional assessment at baseline in all patients and longitudinal follow-up in a subset of 31 patients with RA.

RESULTS

At baseline, patients with RA exhibited significantly higher serum pro-ADM levels (median 51.7 pg/mL) in comparison to PsA, axSpA, and uSpA (median values between 33.9 and 35.6 pg/mL; all P < 0.001). Pro-ADM showed good discriminative ability in distinguishing RA from SpA but had no correlation with markers of inflammation, disease duration, or disease activity indices. In patients with RA with follow-up data, pro-ADM levels exhibited a significant decrease from 52.5 to 30.1 pg/mL after six months (P = 0.023). However, changes in pro-ADM did not correlate with changes in the Disease Activity Score in 28 joints using the C-reactive protein level.

CONCLUSION

Serum pro-ADM levels are markedly elevated in RA relative to SpA, although they do not correlate with inflammatory burden or disease activity. In RA, pro-ADM levels decrease following treatment initiation or modification; nonetheless, they lack predictive value for treatment response. These findings suggest that pro-ADM reflects disease-specific pathophysiologic differences rather than representing a dynamic biomarker.

Для цитирования: Papastathopoulou Nefeli Stavroula, Assirelli Elisa, Neri Simona, Naldi Susanna, Ciaffi Jacopo, Mancarella Luana, Brusi Veronica, Lisi Lucia, Pignatti Federica, Ruscitti Piero, Ursini Francesco. Elevated Serum Proadrenomedullin Levels in Rheumatoid Arthritis Versus Spondyloarthritis: Insights From a Biobank Cohort.. ACR open rheumatology. 2026. DOI: 10.1002/acr2.90061.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.